We came across a bullish thesis on Maze Therapeutics, Inc. on deep market scan subreddit by retroviber. In this article, we will summarize the bulls’ thesis on MAZE. Maze Therapeutics, Inc.’s share was trading at $23.25 as of September 15th. MAZE’s forward P/E was 8.53 according to Yahoo Finance.
Sergey Nivens/Shutterstock.com
Maze Therapeutics (NASDAQ: MAZE) is showing a compelling move in the small-cap biotech space, driven by a rare combination of premium financing, positive...